Robert L. Vender

1.9k total citations · 1 hit paper
19 papers, 1.4k citations indexed

About

Robert L. Vender is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cancer Research. According to data from OpenAlex, Robert L. Vender has authored 19 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 3 papers in Cancer Research. Recurrent topics in Robert L. Vender's work include Cystic Fibrosis Research Advances (6 papers), Neonatal Respiratory Health Research (3 papers) and Tracheal and airway disorders (3 papers). Robert L. Vender is often cited by papers focused on Cystic Fibrosis Research Advances (6 papers), Neonatal Respiratory Health Research (3 papers) and Tracheal and airway disorders (3 papers). Robert L. Vender collaborates with scholars based in United States and United Kingdom. Robert L. Vender's co-authors include Karen A. Robinson, Brian O’Sullivan, Patrick A. Flume, Bruce C. Marshall, Jonathan D. Finder, Christopher H. Goss, Lynne M. Quittell, Leslie Hazle, Peter J. Mogayzel and Mary E. Lester and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Robert L. Vender

18 papers receiving 1.3k citations

Hit Papers

Cystic Fibrosis Pulmonary Guidelines 2007 2026 2013 2019 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Vender United States 12 1.1k 208 205 150 77 19 1.4k
Ori Efrati Israel 28 1.1k 1.0× 284 1.4× 299 1.5× 239 1.6× 53 0.7× 99 1.8k
Yong‐hua Gao China 20 838 0.8× 146 0.7× 223 1.1× 144 1.0× 82 1.1× 54 1.2k
C. Michael Bowman United States 19 1.5k 1.3× 191 0.9× 344 1.7× 232 1.5× 79 1.0× 39 1.9k
Hugh Greville Australia 15 889 0.8× 303 1.5× 153 0.7× 63 0.4× 81 1.1× 40 1.2k
Jang Won Sohn South Korea 21 817 0.7× 308 1.5× 306 1.5× 166 1.1× 76 1.0× 127 1.4k
Yi Yeong Jeong South Korea 19 434 0.4× 102 0.5× 188 0.9× 176 1.2× 13 0.2× 85 1.1k
Carol M. Mason United States 21 540 0.5× 88 0.4× 421 2.1× 287 1.9× 15 0.2× 61 1.7k
Desmond M. Murphy Ireland 19 846 0.8× 482 2.3× 154 0.8× 158 1.1× 66 0.9× 64 1.4k
Theresa A. Laguna United States 17 832 0.8× 73 0.4× 128 0.6× 305 2.0× 52 0.7× 51 1.1k
Yu Ji Cho South Korea 17 416 0.4× 99 0.5× 201 1.0× 115 0.8× 12 0.2× 74 909

Countries citing papers authored by Robert L. Vender

Since Specialization
Citations

This map shows the geographic impact of Robert L. Vender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Vender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Vender more than expected).

Fields of papers citing papers by Robert L. Vender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Vender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Vender. The network helps show where Robert L. Vender may publish in the future.

Co-authorship network of co-authors of Robert L. Vender

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Vender. A scholar is included among the top collaborators of Robert L. Vender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Vender. Robert L. Vender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gordon, Matthew, Robert L. Vender, Parag Desai, et al.. (2021). Venoarterial Extracorporeal Membrane Oxygenation in Massive Pulmonary Embolism-Related Cardiac Arrest: A Systematic Review*. Critical Care Medicine. 49(5). 760–769. 27 indexed citations
2.
Vender, Robert L., et al.. (2016). Clinical Impact of Blood Culture Results in Acutely Ill Hospitalized Adult Patients With Cystic Fibrosis. Journal of Clinical Medicine Research. 8(12). 859–862. 1 indexed citations
3.
Frankenfield, David C., et al.. (2015). Characteristics of Resting Metabolic Rate in Critically Ill, Mechanically Ventilated Adults With Cystic Fibrosis. Journal of Parenteral and Enteral Nutrition. 41(4). 601–606. 6 indexed citations
4.
Conrad, C., James Lymp, Valeria Thompson, et al.. (2014). Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial. Journal of Cystic Fibrosis. 14(2). 219–227. 80 indexed citations
5.
Vender, Robert L., et al.. (2014). Prediction equation to estimate dead space to tidal volume fraction correlates with mortality in critically ill patients. Journal of Critical Care. 29(2). 317.e1–317.e3. 6 indexed citations
6.
Shah, Sapna, et al.. (2013). Characterization of Single and Multiple Antibiotic Allergies in Cystic Fibrosis Patients. Journal of Allergy and Clinical Immunology. 131(2). AB174–AB174. 2 indexed citations
7.
Frankenfield, David C., et al.. (2009). Predicting dead space ventilation in critically ill patients using clinically available data*. Critical Care Medicine. 38(1). 288–291. 22 indexed citations
8.
Flume, Patrick A., Karen A. Robinson, Brian O’Sullivan, et al.. (2009). Cystic Fibrosis Pulmonary Guidelines: Airway Clearance Therapies. Respiratory Care. 54(4). 522–537. 200 indexed citations
9.
Vender, Robert L., et al.. (2009). Cardiac tamponade from acute pericarditis associated with a cystic fibrosis (CF) lung infection. Respiratory Medicine CME. 3(3). 156–159.
10.
Vender, Robert L.. (2008). Cystic Fibrosis Lung Disease in Adult Patients. Postgraduate Medicine. 120(1). 64–74. 2 indexed citations
11.
Flume, Patrick A., Brian O’Sullivan, Karen A. Robinson, et al.. (2007). Cystic Fibrosis Pulmonary Guidelines. American Journal of Respiratory and Critical Care Medicine. 176(10). 957–969. 765 indexed citations breakdown →
12.
Vender, Robert L., David T. Mauger, Susan M. Walsh, Shoaib Alam, & Zachary Simmons. (2007). Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival. Amyotrophic Lateral Sclerosis. 8(1). 36–41. 38 indexed citations
13.
Walsh, Susan, et al.. (2006). A clinical pilot study: High frequency chest wall oscillation airway clearance in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 7(2). 107–111. 34 indexed citations
14.
Vender, Robert L.. (1996). Therapeutic potential of neutrophil-elastase inhibition in pulmonary disease.. PubMed. 44(9). 531–9. 29 indexed citations
15.
Vender, Robert L.. (1994). Chronic Hypoxic Pulmonary Hypertension. CHEST Journal. 106(1). 236–243. 62 indexed citations
16.
Vender, Robert L., Donald H. Horstman, & Salvatore Mangione. (1994). Red Blood Cell Antioxidants in Human Volunteers Exposed to Ozone. Toxicology and Industrial Health. 10(1-2). 53–58. 2 indexed citations
17.
Vender, Robert L.. (1992). Role of endothelial cells in the proliferative response of cultured pulmonary vascular smooth muscle cells to reduced oxygen tension. In Vitro Cellular & Developmental Biology - Animal. 28(6). 403–409. 13 indexed citations
18.
Vender, Robert L., David R. Clemmons, Lester Kwock, & Mitchell Friedman. (1987). Reduced oxygen tension induces pulmonary endothelium to release a pulmonary smooth muscle cell mitogen(s).. PubMed. 135(3). 622–7. 38 indexed citations
19.
Madden, Michael C., Robert L. Vender, & Mitchell Friedman. (1986). Effect of hypoxia on prostacyclin production in cultured pulmonary artery endothelium. Prostaglandins. 31(6). 1049–1062. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026